Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts.
Saved in:
| Title: | Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts. |
|---|---|
| Authors: | Khorki ME; Division of Nephrology & Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Shi T; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States.; Medical Scientist Training Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Cianciolo EE; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Burg AR; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Chukwuma PC; Department of Chemistry & Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, United States., Picarsic JL; Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Department of Pathology, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Morrice MK; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Woodle ES; Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Maltzman JS; Department of Medicine, Stanford University, Palo Alto, CA, United States.; Geriatric Research and Education Clinical Center, Veterans Affairs (VA) Palo Alto Health Care System, Palo Alto, CA, United States., Ferguson A; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Katz JD; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States., Baker BM; Department of Chemistry & Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, IN, United States., Hildeman DA; Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.; Immunology Graduate Program, University of Cincinnati College of Medicine, Cincinnati, OH, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Dec 08; Vol. 14, pp. 1287546. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
